Dendritic cell targeted HIV‐1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8⁺ T cells.

Published in:

Immunity, Inflammation & Disease, 2018, v. 6, n. 1, p. 163, doi. 10.1002/iid3.209

By:

• Ngu, Loveline N.;
• Nji, Nadesh N.;
• Ambada, Georgia;
• Ngoh, Apeh A.;
• Njambe Priso, Ghislain D.;
• Tchadji, Jules C.;
• Lissom, Abel;
• Magagoum, Suzanne H.;
• Sake, Carol N.;
• Tchouangueu, Thibau F.;
• Chukwuma, George O.;
• Okoli, Arinze S.;
• Sagnia, Bertrand;
• Chukwuanukwu, Rebecca;
• Tebit, Denis M.;
• Esimone, Charles O.;
• Waffo, Alain B.;
• Park, Chae G.;
• Überla, Klaus;
• Nchinda, Godwin W.

Publication type:

Article